Published in Pediatr Infect Dis J on October 01, 2008
Immunogenicity of recombinant hepatitis B vaccine: comparison of two different vaccination schedules. Infection (2010) 1.56
Persistence of protection of hepatitis B vaccine and response to booster immunization in 2- to 12-year-old children. Eur J Pediatr (2012) 1.49
The current economic burden of cirrhosis. Gastroenterol Hepatol (N Y) (2011) 1.11
Long-term anti-HBs antibody persistence following infant vaccination against hepatitis B and evaluation of anamnestic response: a 20-year follow-up study in Thailand. Hum Vaccin Immunother (2013) 1.02
Persistence and immune memory to hepatitis B vaccine 20 years after primary vaccination of Thai infants, born to HBsAg and HBeAg positive mothers. Hum Vaccin Immunother (2012) 0.91
Hepatitis B and A vaccination in HIV-infected adults: A review. Hum Vaccin Immunother (2015) 0.89
Immune persistence after hepatitis B vaccination in infancy - Fact or fancy? Hum Vaccin Immunother (2016) 0.86
Serum levels of anti-hepatitis B surface antibody among vaccinated population aged 1 to 18 years in ahvaz city southwest of iran. Hepat Mon (2014) 0.85
The potential of 1018 ISS adjuvant in hepatitis B vaccines: HEPLISAV™ review. Hum Vaccin Immunother (2013) 0.85
Long-term persistence of immunity after vaccination of pre-adolescents with low doses of a recombinant hepatitis B vaccine. Hum Vaccin Immunother (2013) 0.85
Antibody and immune memory persistence post infant hepatitis B vaccination. Patient Prefer Adherence (2013) 0.84
Age-specific prevalence of hepatitis B virus infection in young pregnant women, Hong Kong Special Administrative Region of China. Bull World Health Organ (2014) 0.83
The persistence of anti-HBs antibody and anamnestic response 20 years after primary vaccination with recombinant hepatitis B vaccine at infancy. Hum Vaccin Immunother (2014) 0.83
Prevalence of hepatitis B virus seromarkers in young adults vaccinated at birth; impact on the epidemiology of hepatitis B infection in iran. Hepat Mon (2014) 0.83
HBV vaccination status and response to hepatitis B vaccine among Iranian dentists, correlation with risk factors and preventive measures. Hepat Mon (2014) 0.77
Potential role of killer immunoglobulin receptor genes among individuals vaccinated against hepatitis B virus in Lebanon. World J Hepatol (2016) 0.75
Predictive factors for anti-HBs status after 1 booster dose of hepatitis B vaccine. Medicine (Baltimore) (2016) 0.75
Age-dependent decrease of anti-HBs titers and effect of booster doses using 2 different vaccines in Palestinian children vaccinated in early childhood. Hum Vaccin Immunother (2015) 0.75
Long-term persistence of immunity after hepatitis B vaccination: Is this substantiated by the literature? Hum Vaccin Immunother (2017) 0.75
Strategy vaccination against Hepatitis B in China. Hum Vaccin Immunother (2015) 0.75
Schistosoma mansoni Infection Can Jeopardize the Duration of Protective Levels of Antibody Responses to Immunizations against Hepatitis B and Tetanus Toxoid. PLoS Negl Trop Dis (2016) 0.75
The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol (2006) 10.21
A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: immunization of infants, children, and adolescents. MMWR Recomm Rep (2005) 5.70
A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults. MMWR Recomm Rep (2006) 5.63
Investigation of bioterrorism-related anthrax, United States, 2001: epidemiologic findings. Emerg Infect Dis (2002) 5.23
Ebola 2014--new challenges, new global response and responsibility. N Engl J Med (2014) 5.23
Hepatitis B virus infection: epidemiology and vaccination. Epidemiol Rev (2006) 5.13
Hepatitis A vaccine versus immune globulin for postexposure prophylaxis. N Engl J Med (2007) 4.69
A mathematical model to estimate global hepatitis B disease burden and vaccination impact. Int J Epidemiol (2005) 4.48
Risk of hepatitis C virus infection among young adult injection drug users who share injection equipment. Am J Epidemiol (2002) 4.20
An outbreak of hepatitis A associated with green onions. N Engl J Med (2005) 3.89
Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep (2006) 3.77
Factors associated with fulminant liver failure during an outbreak among injection drug users with acute hepatitis B. Hepatology (2004) 2.78
Changing trends in hepatitis C-related mortality in the United States, 1995-2004. Hepatology (2008) 2.66
Attribution of hepatitis C virus seroconversion risk in young injection drug users in 5 US cities. J Infect Dis (2010) 2.62
Incidence of hepatitis A in the United States in the era of vaccination. JAMA (2005) 2.42
Surveillance for foodborne disease outbreaks - United States, 1998-2008. MMWR Surveill Summ (2013) 2.27
Racial and ethnic distribution of nonalcoholic fatty liver in persons with newly diagnosed chronic liver disease. Hepatology (2005) 2.24
Hepatitis C virus transmission from an anesthesiologist to a patient. Arch Intern Med (2002) 2.11
Incidence and risk factors for acute hepatitis B in the United States, 1982-1998: implications for vaccination programs. J Infect Dis (2002) 2.06
Genome-wide association studies in an isolated founder population from the Pacific Island of Kosrae. PLoS Genet (2009) 2.02
Prevalence of hepatitis C virus infection among injection drug users in the United States, 1994-2004. Clin Infect Dis (2008) 1.86
Effectively introducing a new meningococcal A conjugate vaccine in Africa: the Burkina Faso experience. Vaccine (2012) 1.81
Plasmodium falciparum apical membrane antigen 1 (PfAMA-1) is translocated within micronemes along subpellicular microtubules during merozoite development. J Cell Sci (2003) 1.78
Hepatitis A in the era of vaccination. Epidemiol Rev (2006) 1.75
Antibody levels and protection after hepatitis B vaccine: results of a 22-year follow-up study and response to a booster dose. J Infect Dis (2009) 1.66
Age-specific seroprevalence of HIV, hepatitis B virus, and hepatitis C virus infection among injection drug users admitted to drug treatment in 6 US cities. Am J Public Health (2002) 1.61
Declining hepatitis A mortality in the United States during the era of hepatitis A vaccination. J Infect Dis (2008) 1.57
Chronic liver disease mortality in the United States, 1990-1998. Hepatology (2004) 1.55
The epidemiology of newly diagnosed chronic liver disease in gastroenterology practices in the United States: results from population-based surveillance. Am J Gastroenterol (2008) 1.55
National trends and disparities in the incidence of hepatocellular carcinoma, 1998-2003. Prev Chronic Dis (2008) 1.55
Transmission of HIV and hepatitis C virus from a nursing home patient to a health care worker. Am J Infect Control (2003) 1.53
Epidemiologic investigations of bioterrorism-related anthrax, New Jersey, 2001. Emerg Infect Dis (2002) 1.51
Population-based surveillance for acute liver failure. Am J Gastroenterol (2007) 1.51
Methods to recruit and retain a cohort of young-adult injection drug users for the Third Collaborative Injection Drug Users Study/Drug Users Intervention Trial (CIDUS III/DUIT). Drug Alcohol Depend (2007) 1.50
Linkage analysis of quantitative traits for obesity, diabetes, hypertension, and dyslipidemia on the island of Kosrae, Federated States of Micronesia. Proc Natl Acad Sci U S A (2006) 1.48
Transmission of hepatitis C virus to several organ and tissue recipients from an antibody-negative donor. Ann Intern Med (2005) 1.43
2008 outbreak of Salmonella Saintpaul infections associated with raw produce. N Engl J Med (2011) 1.36
Incidence and transmission patterns of acute hepatitis C in the United States, 1982-2006. Arch Intern Med (2011) 1.35
Surveillance for anthrax cases associated with contaminated letters, New Jersey, Delaware, and Pennsylvania, 2001. Emerg Infect Dis (2002) 1.34
Hepatitis A virus infections in the United States: model-based estimates and implications for childhood immunization. Pediatrics (2002) 1.30
Ongoing transmission of hepatitis B virus infection among inmates at a state correctional facility. Am J Public Health (2005) 1.28
Anthrax postexposure prophylaxis in postal workers, Connecticut, 2001. Emerg Infect Dis (2002) 1.27
Centers for disease control and prevention expert panel meetings on prevention and treatment of anthrax in adults. Emerg Infect Dis (2014) 1.17
Limitations of conventionally derived chronic liver disease mortality rates: Results of a comprehensive assessment. Hepatology (2008) 1.17
Persistence of antibody to hepatitis A virus 10 years after vaccination among children and adults. J Infect Dis (2008) 1.16
Epidemiology of hepatitis B and hepatitis B virus infection in United States children. Pediatr Infect Dis J (2005) 1.14
Cost-effectiveness of routine childhood vaccination for hepatitis A in the United States. Pediatrics (2007) 1.13
National outbreak of Salmonella serotype saintpaul infections: importance of Texas restaurant investigations in implicating jalapeño peppers. PLoS One (2011) 1.10
Differences in response to a hepatitis B vaccine booster dose among Alaskan children and adolescents vaccinated during infancy. Pediatrics (2007) 1.10
Locally acquired hepatitis E virus infection, El Paso, Texas. J Med Virol (2006) 1.08
Identification of patients with hepatitis C virus infection in New Haven County primary care practices. J Clin Gastroenterol (2003) 1.08
Salmonella typhimurium infections associated with peanut products. N Engl J Med (2011) 1.08
Prevalence of infection with waterborne pathogens: a seroepidemiologic study in children 6-36 months old in San Juan Sacatepequez, Guatemala. Am J Trop Med Hyg (2004) 1.07
Hepatitis B vaccination coverage levels among healthcare workers in the United States, 2002-2003. Infect Control Hosp Epidemiol (2007) 1.06
Molecular epidemiology of foodborne hepatitis a outbreaks in the United States, 2003. J Infect Dis (2005) 1.06
Prevalence and correlates of crack-cocaine injection among young injection drug users in the United States, 1997-1999. Drug Alcohol Depend (2005) 1.06
Hepatitis a molecular epidemiology in the United States, 1996-1997: sources of infection and implications of vaccination policy. J Infect Dis (2005) 1.06
The science behind preparing and responding to pandemic influenza: the lessons and limits of science. Clin Infect Dis (2011) 1.04
Quantifying the impact of hepatitis A immunization in the United States, 1995-2001. Vaccine (2004) 1.04
Trends in hepatitis C virus infection among patients in the HIV Outpatient Study, 1996-2007. J Acquir Immune Defic Syndr (2010) 1.04
SARS surveillance during emergency public health response, United States, March-July 2003. Emerg Infect Dis (2004) 1.03
An outbreak of hepatitis B virus infection among methamphetamine injectors: the role of sharing injection drug equipment. Addiction (2006) 1.01
Human Salmonella infections linked to contaminated dry dog and cat food, 2006-2008. Pediatrics (2010) 1.00
Melioidosis Cases and Selected Reports of Occupational Exposures to Burkholderia pseudomallei--United States, 2008-2013. MMWR Surveill Summ (2015) 0.99
High prevalence of overweight among pediatric users of community health centers. Pediatrics (2005) 0.99
Parental knowledge, attitudes, and practices associated with not receiving hepatitis A vaccine in a demonstration project in Butte County, California. Pediatrics (2003) 0.99
The economics of routine childhood hepatitis A immunization in the United States: the impact of herd immunity. Pediatrics (2007) 0.97
Impact of routine hepatitis B immunization on the prevalence of chronic hepatitis B virus infection in the marshall islands and the federated States of micronesia. Pediatr Infect Dis J (2010) 0.96
Outbreak of hepatitis A among men who have sex with men: implications for hepatitis A vaccination strategies. J Infect Dis (2003) 0.94
Chronic liver disease among two American Indian patient populations in the southwestern United States, 2000-2003. J Clin Gastroenterol (2008) 0.94
Hepatitis C virus transmission in hemodialysis units: importance of infection control practices and aseptic technique. Infect Control Hosp Epidemiol (2009) 0.93
A large nosocomial outbreak of hepatitis C and hepatitis B among patients receiving pain remediation treatments. Infect Control Hosp Epidemiol (2004) 0.93
Hepatitis A 2004 vaccination in children: methods and findings of a survey in two states. Am J Prev Med (2007) 0.92
Seroprevalence of hepatitis A virus antibodies in the U.S.: results from the National Health and Nutrition Examination Survey. Public Health Rep (2011) 0.91
Clinical Framework and Medical Countermeasure Use During an Anthrax Mass-Casualty Incident. MMWR Recomm Rep (2015) 0.90
Early Identification and Prevention of the Spread of Ebola - United States. MMWR Suppl (2016) 0.90
Hepatitis A incidence and hepatitis a vaccination among American Indians and Alaska Natives, 1990-2001. Am J Public Health (2004) 0.90
The Ribavirin Pregnancy Registry: Findings after 5 years of enrollment, 2003-2009. Birth Defects Res A Clin Mol Teratol (2010) 0.90
Factors associated with hepatitis a vaccination among children 24 to 35 months of age: United States, 2003. Pediatrics (2006) 0.89
Deaths from chronic liver disease and viral hepatitis, Multnomah County, Oregon, 2000. J Clin Gastroenterol (2007) 0.88
Nosocomial transmission of hepatitis B virus infection among residents with diabetes in a skilled nursing facility. Infect Control Hosp Epidemiol (2002) 0.88
Severe or fatal liver injury in 50 patients in the United States taking rifampin and pyrazinamide for latent tuberculosis infection. Clin Infect Dis (2005) 0.87
Improved anamnestic response among adolescents boosted with a higher dose of the hepatitis B vaccine. Vaccine (2010) 0.87
Transmission of Cryptococcus neoformans by Organ Transplantation. Clin Infect Dis (2011) 0.86
The epidemiology and clinical characteristics of patients with newly diagnosed alcohol-related liver disease: results from population-based surveillance. J Clin Gastroenterol (2010) 0.85
Risk and prevention of acute urinary retention after robotic prostatectomy. J Urol (2012) 0.85
Complementary and alternative medicine use in chronic liver disease patients. J Clin Gastroenterol (2010) 0.85
Identifying optimal vaccination strategies for serogroup A Neisseria meningitidis conjugate vaccine in the African meningitis belt. PLoS One (2013) 0.84